KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,093,858 | -37.0% | 3,456 | -66.3% | 0.00% | -100.0% |
| Q3 2023 | $1,735,540 | -86.6% | 10,264 | -82.9% | 0.00% | -75.0% |
| Q2 2023 | $12,997,338 | +91.3% | 59,937 | +73.3% | 0.00% | +33.3% |
| Q4 2022 | $6,795,167 | -36.8% | 34,581 | -27.7% | 0.00% | -40.0% |
| Q3 2022 | $10,757,000 | +1941.2% | 47,824 | +1048.2% | 0.01% | – |
| Q2 2022 | $527,000 | -94.6% | 4,165 | -94.6% | 0.00% | -100.0% |
| Q1 2022 | $9,767,000 | +72.7% | 77,035 | +78.5% | 0.00% | +50.0% |
| Q4 2021 | $5,654,000 | +1185.0% | 43,158 | +1098.8% | 0.00% | – |
| Q3 2021 | $440,000 | -17.9% | 3,600 | -23.4% | 0.00% | – |
| Q2 2021 | $536,000 | -49.3% | 4,700 | -46.6% | 0.00% | – |
| Q1 2021 | $1,058,000 | -35.1% | 8,800 | -45.2% | 0.00% | – |
| Q4 2020 | $1,630,000 | +33.0% | 16,048 | +1.2% | 0.00% | -100.0% |
| Q3 2020 | $1,226,000 | -81.2% | 15,863 | -72.9% | 0.00% | -75.0% |
| Q2 2020 | $6,517,000 | +710.6% | 58,467 | +447.8% | 0.00% | +300.0% |
| Q4 2019 | $804,000 | – | 10,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |